The NICE guideline "Hypertension in Adults: Diagnosis and Management" outlines recommendations for diagnosing and managing hypertension in adults over 18, including those with type 2 diabetes. It emphasizes accurate blood pressure measurement, recommending ambulatory or home monitoring to confirm di...agnosis. Cardiovascular risk and target organ damage should be assessed, considering age, lifestyle, and other conditions. Initial treatment focuses on lifestyle changes such as diet, exercise, and smoking cessation, with medication advised for stage 1 hypertension at high cardiovascular risk or stage 2 hypertension. Regular monitoring and treatment adjustments are recommended to maintain target blood pressure levels, with specific guidance for people over 80 and those with additional conditions like diabetes or kidney disease. The guideline aims to reduce risks of heart attack, stroke, and other complications, supporting evidence-based treatment decisions in clinical practice.
more
The webpage from the Pan American Health Organization (PAHO) discusses the heightened risk that individuals with noncommunicable diseases (NCDs)—such as cardiovascular diseases, diabetes, and cancer—face regarding severe illness and mortality from COVID-19. It emphasizes the necessity of informi...ng the public about these health risks and adapting healthcare services to ensure the continuity of essential NCD care during the pandemic. The page provides information and guidance for healthcare providers and the public on managing NCDs in the context of COVID-19, highlighting the importance of addressing NCDs and their risk factors with a medium- to long-term perspective.
more
The webpage from the Pan American Health Organization (PAHO) discusses the heightened risk that individuals with noncommunicable diseases (NCDs)—such as cardiovascular diseases, diabetes, and cancer—face regarding severe illness and mortality from COVID-19. It emphasizes the necessity of informi...ng the public about these health risks and adapting healthcare services to ensure the continuity of essential NCD care during the pandemic. The page provides information and guidance for healthcare providers and the public on managing NCDs in the context of COVID-19, highlighting the importance of addressing NCDs and their risk factors with a medium- to long-term perspective.
more
Just under 2.5 million people die annually due to alcohol use. This global estimate, however, excludes most of the health burden
borne by others than the alcohol user. Alcohol’s harm to others includes a multitude of conditions, such as trauma from traffic crashes, fetal disorders due to prenatal... exposure to alcohol, as well as interpersonal and intimate partner violence. While alcohol’s causal role in these conditions is well-established, alcohol’s harm to others’ contribution to the overall health burden of alcohol remains unknown. This knowledge gap leads to a situation in which alcohol policy and prevention strategies largely focus on the reduction of alcohol’s detrimental health harms on the alcohol users, neglecting affected others and population groups most vulnerable to these harms, including women and children. In this article, we seek to elucidate why estimates for alcohol’s harm to others are lacking and offer guidance for future research. We also argue that a full assessment of the alcohol health burden that includes the harm caused by others’ alcohol use would enhance the visibility and public awareness of such harms, and advancing the evaluation of policy interventions to mitigate them.
more
The document, titled "Prevention and Control of Noncommunicable Diseases: Guidelines for Primary Health Care in Low-Resource Settings," provides the World Health Organization's (WHO) recommendations for managing noncommunicable diseases (NCDs) such as cancer, heart disease, diabetes, and chronic res...piratory illnesses in low-resource healthcare settings. It outlines cost-effective interventions for early diagnosis, treatment, and prevention within primary healthcare, focusing on accessible methods for diabetes management, blood pressure control, dietary and lifestyle guidance, and essential medication use. The guidelines aim to support healthcare professionals in delivering effective NCD care where resources are limited, ultimately improving health outcomes and reducing NCD complications.
more
The document, titled "Prevention and Control of Noncommunicable Diseases: Guidelines for Primary Health Care in Low-Resource Settings," provides the World Health Organization's (WHO) recommendations for managing noncommunicable diseases (NCDs) such as cancer, heart disease, diabetes, and chronic res...piratory illnesses in low-resource healthcare settings. It outlines cost-effective interventions for early diagnosis, treatment, and prevention within primary healthcare, focusing on accessible methods for diabetes management, blood pressure control, dietary and lifestyle guidance, and essential medication use. The guidelines aim to support healthcare professionals in delivering effective NCD care where resources are limited, ultimately improving health outcomes and reducing NCD complications.
more
The World Health Organization (WHO) provides a collection of case studies titled "Stories from the Field," highlighting global efforts to prevent and control noncommunicable diseases (NCDs) such as cancer, diabetes, heart, and lung diseases. These narratives showcase how various countries implement ...WHO's technical guidance to improve NCD outcomes through cost-effective and equitable interventions. The stories cover topics like integrating NCD care into primary health systems, enhancing cancer treatment accessibility, and supporting individuals with NCDs during health emergencies. By sharing these experiences, WHO aims to inspire and inform global health initiatives targeting NCDs.
more
This toolkit is a comprehensive set of practical tools and resources designed to support country-level risk communication and community engagement (RCCE) practitioners, decision-makers, and partners to plan and implement readiness and response activities for dengue fever outbreaks. The toolkit conta...ins: information about dengue fever; RCCE considerations for how to approach key issues during dengue fever outbreaks; tools for understanding the context in which dengue fever outbreaks occur; methods for collecting data to inform strategy development and bring evidence into planning and implementation of activities; guidance to support vector control and prevention activities; case studies; and links to existing RCCE tools and training. It is one of a suite of toolkits on RCCE readiness and response to a range of disease and response areas.
more
This document highlights landmarks and key milestones in the development and implementation of the global agenda for noncommunicable diseases (NCDs) over the last two decades. It summarizes where the world was in 2000, where it is in 2022, and where the world wants to be in terms of NCD prevention a...nd control by 2030. It recalls the commitments made by heads of state and governments, and outlines the technical guidance provided by the World Health Organization (WHO) in support of national efforts to achieve the internationally agreed NCD targets for 2025 and 2030.
more
The meeting of leprosy programme managers in the South-East (SE) Asia Region was convened by the WHO Regional Office for South-East Asia (WHO-SEARO) from 11 to 13 April 2023 in Kolkata, India. The meeting was attended by 40 participants, including 15 national focal points from nine countries, five e...xperts, partners, donors and WHO staff members, including those from the Global Leprosy Programme (GLP).
The objectives of the meeting were to:
- review the current situation and progress of leprosy elimination in the Member States;
- discuss the updates on the new guidance and tools from the Global Leprosy Programme;
- facilitate experience-sharing and catalyse discussions to identify innovative practices, solutions and remaining gaps across countries to enhance leprosy elimination activities; and
- determine priority actions and support needs for accelerating leprosy elimination in the Region.
more
The document "Cystic Fibrosis Key Findings 2023 for Care Providers" by the Pennsylvania Department of Health summarizes recent findings and insights related to cystic fibrosis (CF). It highlights key statistics on the prevalence and outcomes of CF, emphasizes best practices for patient care, and pro...vides recommendations for healthcare providers. The document discusses improvements in treatment protocols, advances in medical research, and strategies to enhance patient quality of life. It also includes guidance on early detection, genetic testing, and comprehensive management plans to support affected individuals and their families.
more
The website for the COPD Foundation in South Africa provides information and resources dedicated to raising awareness, improving education, and supporting individuals affected by Chronic Obstructive Pulmonary Disease (COPD). Managed by the C.A.R.E.S. Group (COPD Advocacy, Research, Education, Suppor...t), the site aims to advocate for better COPD management and care. It includes guidance for patients, caregivers, and healthcare professionals, along with updates on research, events, and programs to enhance COPD treatment and support throughout South Africa.
more
The document is an instructional guide in english on how to use a metered-dose inhaler (MDI) with a spacer. It provides detailed, step-by-step instructions for using the device effectively to manage respiratory conditions like asthma. The guide emphasizes the importance of correct technique, prepara...tion of the inhaler, and proper administration to maximize the medication's effectiveness. It also highlights essential points for cleaning the spacer and mentions contacting a healthcare professional for additional assistance or guidance.
more
The document is an instructional guide in arabic on how to use a metered-dose inhaler (MDI) with a spacer. It provides detailed, step-by-step instructions for using the device effectively to manage respiratory conditions like asthma. The guide emphasizes the importance of correct technique, preparat...ion of the inhaler, and proper administration to maximize the medication's effectiveness. It also highlights essential points for cleaning the spacer and mentions contacting a healthcare professional for additional assistance or guidance.
more
The document is an instructional guide in Burmese on how to use a metered-dose inhaler (MDI) with a spacer. It provides detailed, step-by-step instructions for using the device effectively to manage respiratory conditions like asthma. The guide emphasizes the importance of correct technique, prepara...tion of the inhaler, and proper administration to maximize the medication's effectiveness. It also highlights essential points for cleaning the spacer and mentions contacting a healthcare professional for additional assistance or guidance.
more
The document is an instructional guide in Portuguese on how to use a metered-dose inhaler (MDI) with a spacer. It provides detailed, step-by-step instructions for using the device effectively to manage respiratory conditions like asthma. The guide emphasizes the importance of correct technique, prep...aration of the inhaler, and proper administration to maximize the medication's effectiveness. It also highlights essential points for cleaning the spacer and mentions contacting a healthcare professional for additional assistance or guidance.
more
The document is an instructional guide in somali on how to use a metered-dose inhaler (MDI) with a spacer. It provides detailed, step-by-step instructions for using the device effectively to manage respiratory conditions like asthma. The guide emphasizes the importance of correct technique, preparat...ion of the inhaler, and proper administration to maximize the medication's effectiveness. It also highlights essential points for cleaning the spacer and mentions contacting a healthcare professional for additional assistance or guidance.
more
The document is an instructional guide in Spanish on how to use a metered-dose inhaler (MDI) with a spacer. It provides detailed, step-by-step instructions for using the device effectively to manage respiratory conditions like asthma. The guide emphasizes the importance of correct technique, prepara...tion of the inhaler, and proper administration to maximize the medication's effectiveness. It also highlights essential points for cleaning the spacer and mentions contacting a healthcare professional for additional assistance or guidance.
more
Asthma is a heterogeneous condition characterised by chronic inflammation and variable expiratory airflow limitation, with airway reversibility. Management of chronic inflammation with anti-asthma medication improves asthma control and quality of life. The aim of this journal is to provide an eviden...ce-based approach for chronic asthma management in young children and adolescents and provide guidance on the use of new asthma drugs in children.
For that, the South African Childhood Asthma Working Group (SACAWG) convened in January 2017. The asthma treatment task group reviewed the available scientific literature and international asthma treatment guidelines. The evidence was then graded according to the Grades of Recommendation Assessment, Development and Evaluation (GRADE) system and recommendations were made based on scientific evidence and local context. Asthma management recommendations were made for children ˂6 years of age and older children and adolescents, as well as for stepping up and stepping down of therapy. This review does not include biologics or novel asthma drugs, which are covered in another CME article in this edition of SAMJ.
The final conclusions are that it is important to ensure good response, treatment and adherence, type of medication, device and checking of technique are all critical. Stepping up of therapy should be done only after ensuring good adherence and technique. Once therapeutic response is achieved, medication administration has to be stepped down to improve ease of use and avoid unnecessary side-effects.
more
Pneumonia and diarrhoea account for 23% of under-five mortality and were responsible for an estimated 1.17 million deaths in children under five globally. Furthermore, pneumonia and diarrhoea were responsible for 18% of mortality in children 5–9 years of age, resulting in an estimated 86 000 preve...ntable deaths globally in 2021. Existing World Health Organization (WHO) guidance on the clinical management of pneumonia and diarrhoea has mainly focused on children less than 5 years of age.
more